Glass Lewis Proxy Paper Report Recommends "FOR" AIkido Pharm

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on April 20, 2022, the independent Proxy Paper analysis firm...

Related Keywords

Texas , United States , Anthony Hayes , Brett Maas , University Of Maryland At Baltimore , Exchange Commission On , Company Board Of Directors , Company Proxy Statement , Aikido Pharma Inc , Source Aikido Pharma Inc , Nasdaq , While The Company , University Of Texas At Austin , Prnewswire Aikido Pharma Inc , Interest Of The Company , Analysis Firm , Analysis Firm Agrees , Best Interest , Proxy Paper , Glass Lewis , Stockholders May , Exchange Commission , Proxy Statement , Reverse Split , Risk Factors , Managing Partner ,